Researcher profile

Emiel van der Vorst

Priv.-Doz. Dr. Emiel van der Vorst obtained his PhD in Cardiovascular Biology and Medicine from the Cardiovascular Research Institute Maastricht (CARIM), The Netherlands in 2015, by studying the effects of high-density lipoproteins on inflammation. For his postdoctoral period he investigated the role of chemokines and chemokine-receptors in atherosclerosis at the Institute for Cardiovascular Prevention (IPEK) in Munich, Germany, resulting in several high-impact publications. Since 2019, he is working as group leader at the Institute for Molecular Cardiovascular Research (IMCAR) in Aachen, Germany, as well as IPEK. Currently his research is focusing on elucidating various mechanisms by which the lipid metabolism interacts with the immune system in the context of cardiovascular disease, especially atherosclerosis. Furthermore, a main research focus is the identification of novel CVD-relevant kinases in the context of atherosclerosis. His work is funded by various prestigious (inter)national personal grants and he is member of the editorial boards of several cardiovascular focused journals. Furthermore, he is a nucleus member of the Scientists of Tomorrow from the European Society of Cardiology and part of the young fellow programme of the European Atherosclerosis Society.